These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


322 related items for PubMed ID: 27423682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K.
    J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M, Dong X, Zheng Y.
    Medicine (Baltimore); 2021 May 14; 100(19):e25816. PubMed ID: 34106621
    [Abstract] [Full Text] [Related]

  • 9. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec 12; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.
    PLoS One; 2015 Dec 12; 10(3):e0120313. PubMed ID: 25789468
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and pathological findings of patients with interstitial lung disease associated with antisynthetase].
    Hara H, Inoue Y, Sato T.
    Nihon Kokyuki Gakkai Zasshi; 2005 Nov 12; 43(11):652-63. PubMed ID: 16366363
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S.
    J Med Invest; 2018 Nov 12; 65(3.4):251-257. PubMed ID: 30282869
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
    Takato H, Waseda Y, Watanabe S, Inuzuka K, Katayama N, Ichikawa Y, Yasui M, Fujimura M.
    Respir Med; 2013 Jan 12; 107(1):128-33. PubMed ID: 23137883
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.
    Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.
    J Clin Pathol; 2014 Aug 12; 67(8):678-83. PubMed ID: 24891607
    [Abstract] [Full Text] [Related]

  • 20. Myositis-related interstitial lung disease and antisynthetase syndrome.
    Solomon J, Swigris JJ, Brown KK.
    J Bras Pneumol; 2011 Aug 12; 37(1):100-9. PubMed ID: 21390438
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.